Systagenix Reveals New CEO
Ernest Waaser has been appointed CEO and director at Systagenix Wound Management, a UK-based wound care provider. Steve Atkinson, the departing CEO, will continue to work with One Equity Partners as a consultant and advisor on medical device investments. One Equity counts Systagenix—formerly Johnson & Johnson’s wound care business—among its healthcare and medical device portfolio companies.
6 June 2011•2 mins read
